fda compounding semaglutide news alerts health care providers, compounders and patients of dosing errors associated with compounded injectable products FDA free to pursue semaglutide

J., Oudhuis, L., & Priebe, M

PubMed Kajita N, Miyama S, Kinoshita K, Yoshida K, Narita M

When Eli Lilly says 21 days at room temperature, that claim is backed by accelerated stability studies and real-time data submitted to the FDA

As a clinician working with diabetics, the struggle is to try and achieve as much glucose (blood sugar) control as you can to prevent bad complications like kidney failure, retinal disease that can cause blindness and nerve damage that causes loss of sensation in the feet. While insulin injections are an effective treatment, timing the dose and amount is a constant balancing act

If you have news tips, please send them to [email protected]